Bridging the Gap in Diabetes and Fracture Care for Diverse Populations
Nicklas H. Rasmussen

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHip and Femur Fractures · Bone health and osteoporosis research · Hyperglycemia and glycemic control in critically ill and hospitalized patients
The intersection of diabetes and bone health presents a critical, yet often overlooked, challenge in modern medicine. Type 2 diabetes mellitus (T2D), a condition affecting millions globally, is associated with an increased risk of falls and fractures, disproportionately impacting women.^1,2^ These findings resonate with the results presented in the article Ahmed F, Miller K, Beganovic M, Siddiqui A, Smith C. A Sex Comparison of Fall and Fracture Occurrence in the Elderly Diabetic Population: A Quantitative Study. Women’s Health Reports 2025; volume 6, issue 1..
The article highlights significant sex disparities in fracture risk among people with T2D, where women are disproportionately affected despite similar fall rates between sexes. This suggests intrinsic factors—beyond the mechanical impact of falls—play a crucial role in diabetic bone fragility. Such disparities demand a nuanced understanding of the pathophysiology of bone health in T2D and proactive measures to mitigate these risks.
Understanding the Biology of Bone Fragility in T2D
The mechanisms underlying bone fragility in T2D are multifaceted.^3^ Hyperglycemia leads to the accumulation of advanced glycation end-products (AGEs) in bone collagen, impairing bone quality and structural integrity.^4^ Moreover, T2D-related insulin resistance compromises osteoblast function, reducing bone formation.^5^ Physiologically, postmenopausal estrogen deficiency accelerates bone loss, a process compounded by diabetes-induced reductions in bone quality. These biological factors, compounded by sociocultural determinants such as access to health care, socioeconomic status, and cultural practices affecting diet and physical activity, underscore why diabetic women—especially postmenopausal women—face heightened fracture risks.^6^
Sex-Specific Risk and Clinical Implications
Ahmed et al.’s study leverages a retrospective cohort design, allowing for a robust analysis of sex-specific fracture risks in a diverse population. Their findings highlight a significant disparity, with women experiencing a markedly higher fracture rate (50%) compared to men (26%), despite comparable fall frequencies. However, the inherent limitations of retrospective designs, such as potential information bias, should be acknowledged. Although this divergence points to underlying biological and sociocultural factors that amplify fracture risk among women with T2D. Historically, research on bone health and diabetes has predominantly focused on Caucasian cohorts.^7^ Ahmed et al.’s inclusion of a population where 72% are Black addresses this critical gap, providing valuable insights into fracture risks among underrepresented groups. This demographic focus enhances the generalizability of findings, particularly for health care strategies targeting underserved populations. Ahmed et al.’s inclusion of a diverse population underscores the necessity of expanding research frameworks to account for racial and ethnic variability in fracture risk factors, such as access to health care, socioeconomic status, and cultural practices affecting nutrition and physical activity.
Furthermore, behavioral and environmental factors also play a critical role. Women are more likely to adopt protective behaviors postfracture, such as reducing physical activity to avoid future falls. While these adaptations may lower fall risk, they can inadvertently lead to further bone demineralization and muscle atrophy, creating a feedback loop that increases long-term fracture susceptibility. Addressing these behavioral patterns through targeted education and support programs is essential to breaking this cycle.
As emphasized in previous research by Vestergaard and van der Bergh, fracture risk in T2D extends beyond traditional osteoporosis definitions, necessitating more comprehensive diagnostic tools.^8,9^ Advanced imaging methods, including trabecular bone score, high-resolution peripheral quantitative computed tomography, AGE skin readers, and bone biomarkers, may offer a more detailed insight into bone quality within this population.^10–12^
Preventive Strategies
Effective strategies to mitigate fracture risks in diabetic people include early and routine screening for osteoporosis, particularly among postmenopausal women with long-standing diabetes.^13–15^ Interventions should also address glycemic control, as poor glucose management exacerbates bone fragility.^16,17^ Pharmacological therapies, such as bisphosphonates, selective estrogen receptor modulators, or even newer anabolic therapies, should be carefully considered and tailored to individual risk profiles.^18^ Lifestyle modifications are equally crucial. Weight-bearing exercises and strength training can enhance bone density and improve balance, reducing fall risk.^19^ Adequate calcium and vitamin D intake must also be ensured. Notably, culturally sensitive education and community-based interventions are vital to address disparities in fracture risks among diverse populations.^6^ Culturally sensitive education and community-based programs are crucial for addressing disparities in fracture prevention and promoting adherence to comprehensive diabetes management plans. An overview of a multifaceted approach:
- 1.Screening and Diagnosis: Early and routine osteoporosis screening should be prioritized for postmenopausal women and people with long-standing diabetes. Leveraging advanced imaging tools can improve risk stratification and early detection.
- 2.Pharmacological Interventions: Treatment plans must include evidence-based pharmacotherapies, such as bisphosphonates, selective estrogen receptor modulators, or newer anabolic agents, tailored to the patient’s fracture risk profile and glycemic control requirements.
- 3.Lifestyle Modifications: Exercise regimens focused on weight-bearing and resistance training improve bone strength and balance, reducing fall risk. Ensuring adequate intake of calcium and vitamin D remains foundational.
- 4.Culturally Sensitive Education: Community-based programs tailored to diverse populations can address disparities by promoting awareness of fracture prevention strategies and adherence to diabetes management plans.
Contextualizing the Findings in Broader Research
Research from Denmark supports the findings of Ahmed et al., highlighting elevated fracture risks among people with T2D, particularly due to diabetes-related comorbidities.^20^ These studies emphasize the compounded risks arising from impaired postural control and musculoskeletal fragility.^21^ Such data underline the need for integrating musculoskeletal assessments and personalized interventions into standard diabetes care. But also, identifying subtypes of T2D, as not all are equally at risk of falls and fractures.^22^ These approaches aim to preemptively mitigate vulnerabilities and improve long-term outcomes in people with T2D.^23^
The Need for Interdisciplinary Collaboration
The referenced study and related research collectively point to the need for interdisciplinary care models that integrate endocrinology, orthopedics, geriatrics, and primary care. Such collaboration can facilitate holistic care models that address the multifactorial nature of fracture risk in T2D, ensuring personalized and comprehensive patient care.
Conclusion
The intersection of T2D and bone health constitutes a critical challenge in clinical and research domains, necessitating targeted and interdisciplinary solutions. Studies such as Ahmed F, Miller K, Beganovic M, Siddiqui A, Smith C. A Sex Comparison of Fall and Fracture Occurrence in the Elderly Diabetic Population: A Quantitative Study. Women’s Health Reports 2025; volume 6, issue 1,. shine a light on disparities that must inform future prevention strategies. By advancing our understanding of the underlying mechanisms and leveraging interdisciplinary expertise, we can reduce the burden of fractures and improve health outcomes for all people with diabetes.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Rasmussen NH, Dal J. Falls and fractures in diabetes—more than bone fragility. Curr Osteoporos Rep 2019;17(3):147–156.30915638 10.1007/s 11914-019-00513-1 · doi ↗ · pubmed ↗
- 2Guirguis-Blake JM, Michael YL, Perdue LA, et al. Interventions to prevent falls in older adults: Updated evidence report and systematic review for the US preventive services task force. JAMA—JAMA 2018;319(16):1705–1716.10.1001/jama.2017.2196229710140 · doi ↗ · pubmed ↗
- 3Van Hulten V, Rasmussen N, Driessen JHM, et al. Fracture patterns in type 1 and type 2 diabetes mellitus: A narrative review of recent literature. Curr Osteoporos Rep 2021;19(6):644–655.34931295 10.1007/s 11914-021-00715-6PMC 8716348 · doi ↗ · pubmed ↗
- 4Hygum K, Starup-Linde J, Harsløf T, et al. Diabetes mellitus, a state of low bone turnover-a systematic review and meta-analysis. Eur J Endocrinol 2017;176(3):R 137–R 157.28049653 10.1530/EJE-16-0652 · doi ↗ · pubmed ↗
- 5Linde JS, Hygum K, Langdahl BL. Skeletal fragility in type 2 diabetes mellitus. Endocrinol Metab 2018;33(3):339–351.10.3803/En M.2018.33.3.339PMC 614595230229573 · doi ↗ · pubmed ↗
- 6Eastell R, Rosen CJ, Black DM, et al. Pharmacological management of osteoporosis in postmenopausal women: An endocrine society* clinical practice guideline. J Clin Endocrinol Metab 2019;104(5):1595–1622.30907953 10.1210/jc.2019-00221 · doi ↗ · pubmed ↗
- 7Compston J. Type 2 diabetes mellitus and bone. J Intern Med 2018;283(2):140–153.29265670 10.1111/joim.12725 · doi ↗ · pubmed ↗
- 8Starup-Linde J, Vestergaard P. Diabetes and osteoporosis: Cause for concern? Eur J Endocrinol 2015;173(3):R 93–R 99.26243638 10.1530/EJE-15-0155 · doi ↗ · pubmed ↗
